# 2026-08521: FDA Asks: Does Obesity Change Your Pill Dosage? Comment Now!

2026-08521, Obesity and Drug Dosing: Clinical Pharmacology Considerations; Request for Comments, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2026-05-01, effective Submit either electronic or written comments by June 30, 2026.; PRIA reads it as touching household money (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-08521
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-08521
- Title: Obesity and Drug Dosing: Clinical Pharmacology Considerations; Request for Comments
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 23424
- Published: 2026-05-01
- Effective: Submit either electronic or written comments by June 30, 2026.
- Comments close: 2026-06-30
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

FDA Asks: Does Obesity Change Your Pill Dosage? Comment Now!

## Summary

The FDA wants to hear from everyone about how obesity might change the way medicines work and how they should be dosed. This could help make sure people with obesity get the safest and most effective drug doses. If you have ideas, send your comments by June 30, 2026—this could shape future drug rules and impact healthcare costs.

## Abstract

The Food and Drug Administration (FDA) is establishing a public docket entitled "Obesity and Drug Dosing: Clinical Pharmacology Considerations." The Agency is soliciting input from interested persons on assessing the effect of obesity on drug pharmacokinetics and pharmacodynamics during drug (including biological product) development. These assessments could potentially inform whether obesity impacts the safety and effectiveness of the drug and dosing recommendations for obese patients.

## Effects PRIA read

- FDA Seeks Input on Obesity and Drug Dosing: benefit, medium. If you have obesity or care for a child with obesity, the FDA is asking for public comments by June 30, 2026 (Docket No. FDA-2026-N-3499) about how obesity changes drug effects and whether dosing recommendations should differ. The notice cites that about 40% of adults and about 20% of children have…

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2026-08521 on federalregister.gov](https://www.federalregister.gov/documents/2026/05/01/2026-08521/obesity-and-drug-dosing-clinical-pharmacology-considerations-request-for-comments)
- [2026-08521 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-05-01/pdf/2026-08521.pdf)

## Related
- [Previous: 2026-08520, Environmental Impact Statements; Notice of Availability](https://policyrisk.com/federal-register/2026-08520)
- [Next: 2026-08522, Change in Bank Control Notices; Acquisitions of Shares of a Bank or Bank Holdin…](https://policyrisk.com/federal-register/2026-08522)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-08521 (as of 2026-06-08).
